Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for cancer and autoimmune disease.
86 employees · est. 2020 · Cambridge, United States
Tizona Therapeutics, Inc.
Harnessing the power of the immune system to develop treatments for cancer.
23 employees · est. 2015 · South San Francisco, United...
Tizona Therapeutics, Inc. is the older company (2020 vs 2015); Repertoire Immune Medicines is the larger of the two.
Side-by-Side Comparison
| Metric | Repertoire Immune Medicines | Tizona Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2015 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | South San Francisco, United States |
| Employees | ||
| Employees | 86 larger | 23 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series B | Unknown |
| Total Funding | ||
| Total Funding | $189.00M | $343.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Discovery of Immune Codes, Development of Targeted Immune Medicines, Therapeutic Solutions for Cancer, Therapeutic Solutions for Autoimmune Diseases | Development of first-in-class immunotherapies, Clinical trial execution, Research and development of novel cancer treatments |
| Target Customers | ||
| Target Customers | Patients with Cancer, Patients with Autoimmune Diseases, Healthcare Providers, Pharmaceutical Partners | Cancer patients, Healthcare providers, Pharmaceutical companies, Research institutions |
| Taxonomy | ||
| Taxonomy | Immune Medicines, Cancer Treatment, Autoimmune Disease Treatment, T Cell Repertoire, Immune Synapse, DECODE Platform, T Cell Receptor-epitope Pairs, Immune-based Medicines, Clinical Stage Biotechnology, Autologous T Cell Therapy, IL-15 Tethering, Infectious Disease Treatment, Immune System Innovation, Phenotype Analysis | Immunology, Cancer Treatment, Autoimmune Disease Treatment, Immune System Modulation, Immunosuppressive Cell Modulation, Tumor Microenvironment, Cell Therapy, Biological Mechanisms, Immune-Oncology, Immune System Activation, Biotech Start-Up, Cancer Immunotherapy, Autoimmunity Control |
| Website | ||
| Website | repertoire.com | tizonatx.com |
About Repertoire Immune Medicines
Repertoire Immune Medicines is at the forefront of developing a new wave of immune medicines, leveraging its expertise in the biotechnology sector. Founded in 2020 and headquartered in the United States, the company uniquely harnesses the potential of the human T cell repertoire to combat cancer, ta...
About Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc., founded in 2015, is a biotechnology company focusing on immunology to develop treatments for cancer and autoimmune diseases. The company, established by MPM Capital and prominent scientists from leading institutions like the Dana Farber Cancer Institute and Johns Hopkins,...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Repertoire Immune Medicines and Tizona Therapeutics, Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Repertoire Immune Medi... and Tizona Therapeutics, I... — by email.
Frequently Asked Questions
Compare Repertoire Immune Medicines with someone else
Start typing a company name or domain.